Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-target Resection Compared With Full-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma: a Multicentre, Randomised, Open-label, Phase 3 Trial

NCT05877872 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT05877872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05877872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-target Resection Compared With Full-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma: a Multicentre, Randomised, Open-label, Phase 3 Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
May 20, 2023
Completion date
March 30, 2029
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de-escaltion therapy, nasopharyngeal carcinoma